2m 2m 2m 2m 2m 2m 2m
Nuo Therapeutics (AURX)
OTC
$1.25$0.00 (0.00%)
Price as of Sep 11, 2026- $60.5MMarket Cap
- -28.98%1-Year Change
- BiotechnologyIndustry
Nuo Therapeutics (AURX)
$1.25$0.00 (0.00%)
AURX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.25 | ||
Change | $0.00 (0.00%) | ||
Open | $1.28 | ||
High | $1.28 | ||
Low | $1.25 | ||
Previous Close | $1.25 | ||
Volume | 600 | ||
30-Day Average Volume | 6,554 | ||
1-Week Change | 3.31% | ||
1-Month Change | 47.06% | ||
1-Year Change | -28.98% | ||
3-Year Change | 83.82% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.4M | ||
Total Assets | $2.6M | ||
Market Cap | $60.5M | ||
Enterprise Value | $61.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$277,601.00 | ||
Free Cash Flow | -$489,502.00 | ||
EBIT | -$163,535.00 | ||
EBITDA | -$137,337.00 | ||
Net Working Capital | $439,434.00 | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -448 | ||
Enterprise Value/Revenue | 36 | ||
P/B | -39 | ||
P/E | -125 | ||
PEG | N/A | ||
Price/Free Cash Flow | -124 | ||
Price/Operating Cash Flow | -256 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue